Results of a study investigating Pirtobrutinib for treatment of relapsed chronic lymphocytic leukemia and mantle cell lymphoma. (Abstract only)
Home / Resource Library / Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study